These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3282464)

  • 21. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide attenuates beryllium-induced IFNgamma responses in chronic beryllium disease: evidence for mechanisms independent of IL-18.
    Barna BP; Dweik RA; Farver CF; Culver D; Yen-Lieberman B; Thomassen MJ
    Clin Immunol; 2002 May; 103(2):169-75. PubMed ID: 12027422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent chronic beryllium disease in residents surrounding a beryllium facility.
    Maier LA; Martyny JW; Liang J; Rossman MD
    Am J Respir Crit Care Med; 2008 May; 177(9):1012-7. PubMed ID: 18244954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sarcoidosis and berylliosis].
    Soriano D; Quartucci C; Agarwal P; Müller-Quernheim J; Frye BC
    Internist (Berl); 2022 May; 63(5):557-565. PubMed ID: 35397695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum angiotensin converting enzyme activity in chronic beryllium disease.
    Newman LS; Orton R; Kreiss K
    Am Rev Respir Dis; 1992 Jul; 146(1):39-42. PubMed ID: 1320822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differential diagnosis of berylliosis/sarcoidosis in a dental technician].
    Müller-Quernheim J; Zissel G; Schopf R; Vollmer E; Schlaak M
    Dtsch Med Wochenschr; 1996 Nov; 121(47):1462-6. PubMed ID: 8983896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.
    Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP
    Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
    Fontenot AP; Canavera SJ; Gharavi L; Newman LS; Kotzin BL
    J Clin Invest; 2002 Nov; 110(10):1473-82. PubMed ID: 12438445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible beryllium sensitization in a prospective study of beryllium workers.
    Rom WN; Lockey JE; Bang KM; Dewitt C; Johns RE
    Arch Environ Health; 1983; 38(5):302-7. PubMed ID: 6651355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells.
    Saltini C; Winestock K; Kirby M; Pinkston P; Crystal RG
    N Engl J Med; 1989 Apr; 320(17):1103-9. PubMed ID: 2469014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Aminosalicylic Acid Modulates the Immune Response in Chronic Beryllium Disease Subjects.
    Day BJ; Huang J; Barkes BQ; Gillespie M; Li L; Maier LA
    Lung; 2018 Feb; 196(1):103-114. PubMed ID: 29080069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
    Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis of chronic berylliosis].
    Schreiber J; Zissel G; Greinert U; Galle J; Schulz KH; Schlaak M; Müller-Quernheim J
    Pneumologie; 1999 Apr; 53(4):193-8. PubMed ID: 10409861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening blood test identifies subclinical beryllium disease.
    Kreiss K; Newman LS; Mroz MM; Campbell PA
    J Occup Med; 1989 Jul; 31(7):603-8. PubMed ID: 2788726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases.
    Phalke S; Aviszus K; Rubtsova K; Rubtsov A; Barkes B; Powers L; Warner B; Crooks JL; Kappler JW; Fernández-Pérez ER; Maier LA; Hamzeh N; Marrack P
    Am J Respir Crit Care Med; 2020 Oct; 202(7):1013-1023. PubMed ID: 32501729
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chronic Beryllium disease after exposure to low-beryllium-content copper].
    Hasejima N; Kobayashi H; Takezawa S; Yamato K; Kadoyama C; Kawano Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1105-10. PubMed ID: 8544383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of beryllium in lung tissue of a chronic beryllium disease case and cases with sarcoidosis.
    Verma DK; Ritchie AC; Shaw ML
    Occup Med (Lond); 2003 May; 53(3):223-7. PubMed ID: 12724557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short- and long-term response to corticosteroid therapy in chronic beryllium disease.
    Marchand-Adam S; El Khatib A; Guillon F; Brauner MW; Lamberto C; Lepage V; Naccache JM; Valeyre D
    Eur Respir J; 2008 Sep; 32(3):687-93. PubMed ID: 18757698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease.
    Fontenot AP; Kotzin BL; Comment CE; Newman LS
    Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 65-year-old factory worker with dyspnea on exertion and a normal chest x-ray.
    Saber W; Dweik RA
    Cleve Clin J Med; 2000 Nov; 67(11):791-2, 794, 797-8, 800. PubMed ID: 11104328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.